GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ToolGen Inc (XKRX:199800) » Definitions » LT-Debt-to-Total-Asset

ToolGen (XKRX:199800) LT-Debt-to-Total-Asset : 0.65 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is ToolGen LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. ToolGen's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.65.

ToolGen's long-term debt to total assets ratio increased from Dec. 2022 (0.00) to Dec. 2023 (0.65). It may suggest that ToolGen is progressively becoming more dependent on debt to grow their business.


ToolGen LT-Debt-to-Total-Asset Historical Data

The historical data trend for ToolGen's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ToolGen LT-Debt-to-Total-Asset Chart

ToolGen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.65

ToolGen Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.65

ToolGen LT-Debt-to-Total-Asset Calculation

ToolGen's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=60409.389/93450.754
=0.65

ToolGen's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )/Total Assets (Q: Dec. 2023 )
=60409.389/93450.754
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ToolGen  (XKRX:199800) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


ToolGen LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of ToolGen's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


ToolGen (XKRX:199800) Business Description

Traded in Other Exchanges
N/A
Address
KOR-collar Gasan Digital Valley 1 to 219 digital Byeoksan, 6th 1204 No. ENG No. 1204, Byucksan Digital Valley 6-cha, 219 Gasan Digital 1-ro, Geumcheon-gu, Seoul, KOR
ToolGen Inc is a biotechnology company, which focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified, gRNA/Cas9, and recombinant Cas9 protein, which offers ready-to-use reagents for genome engineering experiments. The company also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services.

ToolGen (XKRX:199800) Headlines

No Headlines